You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
達嘉維康(301126.SZ):擬收購安徽達嘉維康60.85%股權

格隆匯7月11日丨達嘉維康(301126.SZ)公佈,董事會同意公司以自有資金或自籌資金收購安徽達嘉維康60.85%的股權,公司擬與安徽達嘉維康股東馬鞍山市健康大藥房有限公司(簡稱“馬鞍山健康”)、高元斌簽署《股權收購協議》,本次交易完成後安徽達嘉維康成爲公司控股子公司,納入公司合併報表範圍。根據北京坤元至誠資產評估有限公司出具的《湖南達嘉維康醫藥產業股份有限公司擬收購安徽達嘉維康健康大藥房有限公司股權涉及的該公司股東全部權益市場價值資產評估報告》(京坤評報字[2025]0543號),以2025年4月30日爲基準日,安徽達嘉維康股東全部權益評估值爲19,030.00萬元。經雙方協商並參考評估價值,確定本次交易價格爲11,561.50萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account